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Psoriasis is a heterogeneous disease for which nine linkage loci (PSORS loci 1–5 and PSORS7–10) have been
accepted by the Human Genome Nomenclature Committee and an additional 16 potential susceptibility loci
have been reported so far. Our previous genome-wide scan in 61 Chinese Han psoriasis vulgaris families found
two susceptibility loci at 6p21.3 and 4q31 and additional suggestive linkage evidence at other regions, including
9q33. In this follow-up study, the linkage evidence at 9q33 was further investigated using an expanded sample of
160 families and improved marker coverage. Our follow-up linkage analysis of the 160 families demonstrated
strong linkage evidence (Pp0.000022) throughout a region between 133.38 and 146.23 cM with a maximum
nonparametric linkage (NPL) score of 4.64 (P¼ 0.00000023) and a heterogeneity LOD (HLOD) score of 5.03
(a¼ 46%) at 142.39 cM near the marker D9S290. By stratifying the 160 families into the subtypes of 130 early-onset
and 30 late-onset families, we revealed stronger linkage evidence in the early-onset psoriasis families with a
maximum multipoint HLOD score of 6.48 (a¼ 58%) and a maximum NPL score of 4.69 (P¼ 0.00000012) near
marker D9S290. Our follow-up study has confirmed a novel susceptibility locus at 9q33–34 for early-onset
psoriasis in the Chinese population.
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INTRODUCTION
Psoriasis is a common, immunologically mediated, and
hyperproliferative skin disease characterized by strong
familial aggregation (Elder et al., 1994; Zhang et al., 2000).
It has a worldwide distribution, with prevalence varying
among races and geographical locations. Its estimated
prevalence is 2–5% in the Caucasian population (Nevitt
and Hutchinson, 1996) and 0.123% in the Chinese popula-
tion (Shao, 1996). Psoriasis is associated with epidermal
growth in a pattern termed ‘psoriasiform’ hyperplasia:
keratinocytes proliferate and mature rapidly. Normally
terminal differentiation occurs in granular keratinocytes,
and the incomplete squamous corneocytes formation and
poorly adherent stratum corneum result in the characteristic
flakes of psoriasis lesions (Krueger and Bowcock, 2005).
Recent studies suggested that psoriasis vulgaris is the most
prevalent autoimmune disease caused by inappropriate
activation of the T-cellular immune system. Some proin-
flammatory molecules and cytokines such as IL-1 and tumor
necrosis factor-a are released from keratinoyctes and there is
convergence of the tumor necrosis factor-a and IFN-g
signaling pathways in psoriasis, which is mediated by a
composite IFN-g activating sequence/kappa B promoter
element. Both tumor necrosis factor-a and IFN-g are
important cytokines of the innate immune system and play
an important role in the pathogenesis of psoriasis (Pine, 1997;
Lowes et al., 2004).
Genetic analyses of families with psoriasis had identified
several susceptibility loci for psoriasis on various chromo-
somes (Bowcock and Cookson, 2004; Friberg et al., 2006).
One of the most compelling susceptibility loci for psoriasis is
the PSORS1 locus in the major histocompatibility complex
region where the disease risk has been consistently shown to
be strongly associated with the (human leukocyte antigen)-
Cw*0602 allele that can be found in 10% of healthy northern
European controls and 50% of psoriasis patients (Rahman and
Elder, 2005).
To search for the psoriasis susceptibility genes in the
Chinese population, a genome-wide scan was performed by
our group in 61 Chinese Han families with psoriasis vulgaris
in 2002. Our genome scan study found two strong suscept-
ibility loci at 6p21 and 4q31 and suggestive evidence for
linkage on several other regions including 9q33 (Zhang et al.,
2002). In this study, we further investigated the suggested
linkage to 9q33 by using an expanded sample of families and
improved marker coverage.
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RESULTS
Two-point and multipoint parametric and nonparametric
linkage (NPL) analyses were first performed using all 160
families and nine markers within the region under study. The
analysis of the 160 families revealed significant linkage
evidence (Pp0.000022), throughout the region between
133.38 and 146.23 cM, with a maximum multipoint NPL
score of 4.64 (P¼0.00000023) and a maximum multipoint
heterogeneity LOD (HLOD) of 5.03 (a¼46%) near the
marker D9S290. We then performed the linkage analysis
using the 61 original families and the 99 new families
separately. The overall linkage patterns from the two
independent family cohorts were very similar to the one
from all 160 families. The analysis of the 61 original families
yielded a maximum multipoint HLOD of 1.76(a¼ 36%) and
a maximum multipoint NPL score of 2.90 (P¼0.002), close
to the marker D9S290, whereas the analysis of the 99 new
families yielded a maximum multipoint HLOD of 4.49
(a¼64%) and a maximum multipoint NPL score of 3.67
(P¼0.000003) at the same marker (Figure 1). The linkage
analysis was also performed using the stratified samples of the
130 early-onset and 30 late-onset families. The analysis of the
early-onset families gave a maximum multipoint HLOD of
6.48 (a¼ 58%) and a maximum multipoint NPL score of 4.69
(P¼0.00000012) at the same genetic position (Figure 1c),
whereas the analysis of the late-onset families only revealed
very weak linkage evidence (data not shown).
DISCUSSION
To date, the pathogenesis of psoriasis is only partially
understood. Psoriasis is generally believed to be a type 1 T-
cell-mediated autoimmune disease linked to many interac-
tive responses between infiltrating leukocytes, resident skin
cells and an array of proinflammatory cytokines, chemokines,
and chemical mediators produced in the skin under regula-
tion of the cellular immune system (Lowes et al., 2004;
Krueger and Bowcock, 2005). Nine linkage loci to psoriasis
(PSORS loci 1–5 and PSORS7–10) were accepted by the
Human Genome Nomenclature Committee, and 16 potential
psoriasis susceptibility loci have been reported so far.
(Trembath et al., 1997; Samuelsson et al., 1999; Lee et al.,
2000; Veal et al., 2001; Zhang et al., 2002; Asumalahti et al.,
2003; The International Psoriasis Genetics Consortium, 2003;
Friberg et al., 2006). Independent replications of most of
these linkage findings, however, have proved to be difficult,
which is likely due to the etiological complexity of psoriasis.
Not only is the phenotype influenced by many environmental
factors, but the susceptibility to psoriasis is also affected by
genetic heterogeneity and ethnic variation of relevant genes.
Evidence for linkage to 9q33 was first identified by our
group in 61 Chinese Han psoriasis vulgaris families through a
genome-wide scan (Zhang et al., 2002). In this study, we
further investigated our initial linkage finding by analyzing
more families and more markers surrounding the original
linkage peak. The parametric and nonparametric multipoint
linkage analyses of the 61 original and 99 new families
yielded independent significant evidence for linkage to
9q33 (HLOD¼ 1.76 and NPL score¼ 2.90, P¼0.002;
HLOD¼4.49 and NPL score¼3.67, Po0.000022, respec-
tively), and the joint analysis of all 160 families provided
stronger evidence for the linkage to 9q33 (HLOD¼5.03 and
NPL score¼4.64, Po0.000022). Furthermore, by stratifying
our families into early-onset and late-onset ones in linkage
analysis, we identified highly significant linkage evidence in
the early-onset families (HLOD¼6.48 and NPL score¼4.69,
Po0.000022) that is above the threshold for significance at
the genome level (Lander and Kruglyak, 1995). Therefore, the
highly significant linkage evidence from our follow-up study
using an expanded sample of families and improved marker
coverage supported our initial linkage finding and confirmed
the linkage of psoriasis to 9q33 in Chinese Han population.
Interestingly, our results also suggest that the evidence for
linking psoriasis to 9q33 is mainly from the early-onset
families. By stratifying the families into early- and late-onset
ones in linkage analysis, evidence for linkage was only
detected in the early-onset families, not in the late-onset
families. More importantly, the linkage evidence from the
130 early-onset families (HLOD¼6.48 and NPL
score¼ 4.69) is stronger than the evidence from all 160
families (HLOD¼ 5.03 and NPL score¼ 4.64), although the
difference is only marginal. Meanwhile, it needs to be
pointed out that the number of the late-onset families is much
smaller than the number of the early-onset families, so the
linkage analysis of the late-onset families is underpowered
compared to the analysis of the early-onset families. It is
possible that the failure to detect the linkage evidence in the
late-onset families is due to the limited power of the late-
onset family sample. Having said that, the fact that the
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Figure 1. The overall evidence for the linkage to 9q33-34. The plot shows the results of the (a) multipoint HLOD and (b) NPL scores from 160 psoriasis families
(—), 61 original families (— - —) and 99 new families (- - - -) within the 9q33–34 region calculated by GENEHUNTER version 2.0. (c) The plot shows the results
of multipoint NPL scores (- - - -) and HLOD (—) from 130 early-onset psoriasis families at 9q33–34 calculated by GENEHUNTER version 2.0.
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smaller sample of the 130 early-onset families provides
stronger linkage evidence than the larger sample of all 160
families does suggest that the evidence for linkage to 9q33 is
mainly from the early-onset families. Still subject to further
validation by additional studies, our results suggest that the
unknown susceptibility allele within this linkage locus will
play a more important role in early-onset psoriasis than in the
late-onset disease.
Based on the National Center for Biological Information
database there are currently 163 genes such as SH2D3C,
ANGPTL2, Homolog B (Caenorhabditis elegans)-like gene
annotated within this linkage region of 10 cM flanked by
markers D9S1682 and D9S1847 (Po0.000022). SH2D3C
and ANGPTL2 may represent interesting functional
candidates because they have features that fit the present
understanding of psoriasis pathogenesis (Salim and Emerson,
2001; Lowes et al., 2004; Krueger and Bowcock, 2005;
Zhang et al., 2005). The Homolog B (Caenorhabditis
elegans)-like gene which is located next to Marker D9S290
(associated with the strongest linkage evidence) is also an
interesting candidate. However, the candidate region defined
in this study is still relatively large with a large number of
known genes as well as transcripts without annotation. It is
still very challenging to select a strong candidate gene for
sequencing and functional analysis. Further fine-mapping
analysis is warranted.
In conclusion, our follow-up study using the expanded
sample of 160 families and improved marker coverage
provides confirmatory evidence for linkage to 9q33–34 in
Chinese Han psoriasis vulgaris families. Interestingly, our
study further demonstrates that the linkage evidence is mainly
from the early-onset families, suggesting that the suscept-
ibility genes within this linkage locus likely play an important
role in the pathogenesis of early-onset psoriasis. There are
several interesting candidate genes within the linkage region
whose roles in the development of psoriasis need to be
evaluated. We are currently working on a fine-mapping
analysis in which genetic association analysis will be
performed using a dense array of single-nucleotide poly-
morphisms within the linkage region with the goal of
identifying the underlying genetic susceptibility variants for
psoriasis.
MATERIALS AND METHODS
Study samples
A total of 160 Chinese Han psoriasis vulgaris families, including the
61 families used in our original genome-wide scan and 99 new
families, were recruited from the Dermatology Department at the
First Hospital of the Anhui Medical University. The ascertainment
scheme of these families has been described in detail elsewhere
(Zhang et al., 2002). The families were divided into two groups: early
onset and late onset (Szczerkowska-Dobosz et al., 1996). The early-
onset group includes 130 families in which the patient’s age of onset
isp40 years; the late-onset group includes 30 families in which the
patient’s age of onset is 440 years (Table 1). All the participating
individuals provided informed written consent. The study was
approved by the Ethical Committee of the Anhui Medical University
and was conducted according to the Declaration of Helsinki
Principles.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using standard procedures (Miller et al., 1988). For the fine mapping
analysis of the chromosome 9q33–34 region, a framework genetic
map was constructed encompassing the prior linkage region
anchored by markers D9S1776 and D9S1826 flanking the original
peak markers D9S1682 and D9S290 (Table 2).
Primer sequences, expected allele size information, and hetero-
zygosity for each marker were obtained from the Genome Database
(http://gdbwww.gdb.org/). Information content, as evaluated by
using the Hidden Markov Model implemented in GENEHUNTER
(Lander and Kruglyak, 1995; Rijsdijk and Sham, 2002), increased
from 80 to 86% in the region of the linkage peak marker D9S290
following the addition of eight markers.
PCRs were carried out in a 5 ml volume containing 10 ng DNA,
10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.1 mg/ml gelatin, 3.0 mM
MgCl2, 0.2 mM each of deoxynucleoside triphosphate, 0.04 mM of
each primer (the forward primer labeled with 6-fluorochrome 6-
caboxyl-fluorescein fluorescent dye), and 0.2 U Hotstar Taq DNA
polymerase (Qiagen, CA). PCR reactions were carried out on a ABI
9700 (Applied Biosystems, CA) Thermal Cycler using the following
protocol: Hotstar Taq activation at 951C for 15 minutes, followed by
40 cycles with denaturation at 941C for 30 seconds, annealing at
561C for 60 seconds and extension at 721C for 90 seconds except
that in the first 15 cycles the annealing temperature decreased from
Table 1. Details of psoriasis families used for linkage analysis
Phenotypes Total family members Total affected members 61 original families’ affected members 99 new families’ affected members
Psoriasis vulgaris 746 416 189 227
Early onset1 586 327 147 180
Males 294 189 82 107
Females 292 138 65 73
Late onset2 160 89 42 47
Males 90 56 25 31
Females 70 33 17 16
1The patient’s age at onset p40 year (Szczerkowska-Dobosz et al., 1996).
2The patient’s age at onset440 year (Szczerkowska-Dobosz et al., 1996).
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63 to 561C by 0.51C per cycle and the final extension was 721C for
10 minutes. (Don et al, 1991).
The PCR products were separated on an automated ABI PRISM
3730 DNA sequencer (Applied Biosystems). GeneMapper 3.0
software (Applied Biosystems) was used for determining fragment
sizes. All genotypes were scored and reviewed independently by two
observers and retyped in case of discrepancy. All markers were
examined for Mendelian inconsistencies and genotyping errors using
PedCheck (O’Connell and Weeks, 1998). Double recombinations
were identified, and the corresponding families were genotyped
again. Where an inconsistency could not be resolved, the family was
set to have all data missing at that specific marker (on average 1% of
the families were set to missing status).
Statistical analysis
Two-point and multipoint HLOD scores were calculated by affected-
only analysis using GENEHUNTER 2.0. and assuming a dominant
mode of inheritance with a disease allele frequency of 0.00062 that
is consistent with the disease prevalence of 0.123% in China (Shao,
1996). Under the assumption of locus heterogeneity, HLOD scores
were maximized for varying fractions of linked families (alpha) by
use of GENEHUNTER (Kruglyak et al., 1996). We also performed
two-point and multipoint ‘model-free’ NPL analyses using GENE-
HUNTER 2.0. NPL analysis is robust even when the mode of
inheritance is uncertain. As suggested by Lander and Kruglyak
(1995), Po3.0 107 was considered highly significant,
Po2.2 105 was considered statistically significant, P-value
between 2.2 105 and 7.4 104 was considered suggestive
evidence for linkage.
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